表紙
市場調查報告書

細胞化驗分析 & 高內涵篩選 (HCS)的全球市場:預測及分析

Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2020 to 2024

出版商 Howe Sound Research 商品編碼 854114
出版日期 內容資訊 英文 235 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
細胞化驗分析 & 高內涵篩選 (HCS)的全球市場:預測及分析 Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2020 to 2024
出版日期: 2019年11月02日內容資訊: 英文 235 Pages
簡介

本報告提供全球細胞化驗分析 & 高內涵篩選 (HCS) 市場相關調查,技術,市場趨勢,發展趨勢,及主要企業的分析,各用戶類型、產品類型的市場,各地區、種類的市場規模等資料。

第1章 簡介與市場定義

  • 細胞化驗分析是什麼?
  • 臨床實驗的失敗
  • 市場定義
  • 調查手法
  • 美國的醫療市場、醫藥品研究費 - 展望

第2章 細胞化驗分析:技術指南

  • 細胞培養
  • 細胞化驗
  • 細胞生存化驗
  • 細胞生長化驗
  • 細胞毒性化驗
  • 細胞老化化驗
  • 細胞凋亡
  • 自動模糊
  • 壞死
  • 氧化壓力
  • 2D vs. 3D
  • 信號傳達途徑,GPCR
  • 免疫製作 & 阻礙
  • 報導基因技術
  • CBA設計 & 開發
  • 細胞化驗分析:彙整

第3章 產業概要

  • 市場參與企業

第4章 市場趨勢

  • 成長促進因素
  • 阻礙成長的要素
  • 技術開發

第5章 細胞化驗分析的近幾年的發展趨勢

  • 近幾年的發展趨勢

第6章 主要細胞化驗分析企業的簡介

  • Abcam
  • Agilent
  • Beckman Coulter, Inc.
  • Becton Dickinson
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories, Inc.
  • Cisbio Bioassays
  • Corning, Inc.
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • GE Healthcare Life Sciences
  • Hemogenix
  • Horizon Discovery Group plc
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Merck KgaA
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc.
  • Olympus
  • Origene Technologies
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen NV
  • Reaction Biology
  • Roche Group
  • Sartorius
  • Sony Biotechnology
  • Stemcells Technologies Canada Inc.
  • Thermo Fisher Scientific, Inc.
  • TTP Labtech
  • Vitro Biopharma

第7章 世界市場規模

  • 全球細胞化驗分析市場規模:各地區 (附圖表)
  • 全球細胞化驗分析市場規模:各類型 (附圖表)

第8章 全球市場:各用戶類型

  • 醫藥品市場
  • 基礎研究市場
  • 工業/化妝品市場

第9章 細胞化驗分析:各產品類型

  • 設備市場
  • 試劑市場
  • 服務市場
  • 軟體市場

第10章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

OVERVIEW:

Cell Based Assays are a mainstay of drug development and scientific research, but growth is now accelerating as new immuno-oncology markets create unprecedented investment in the race to cure cancer. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 What are Cell Based Assays?
  • 1.2 Clinical Trial Failures
    • 1.2.1 Immuno-oncology Plays a Leading Role in Cell Based Assays
  • 1.3 Market Definition
    • 1.3.1 Market Size
    • 1.3.2 Currency
    • 1.3.3 Years
  • 1.4 Methodology
    • 1.4.1 Authors
    • 1.4.2 Sources
  • 1.5 U.S. Medical Market and Pharmceutical Research Spending - Perspective
    • 1.5.1 U.S. Expenditures for Pharmaceutical Research

2. Cell Based Assays - Guide to Technology

  • 2.1 Cell Cultures
    • 2.1.1 Cell Lines
    • 2.1.2 Primary Cells
    • 2.1.3 Stem Cells
      • 2.1.3.1 iPSC's - The Special Case
  • 2.2 Cell Assays
  • 2.3 Cell Viability Assays
  • 2.3 Cell Proliferation Assays
  • 2.4 Cytotoxicity Assays
  • 2.5 Cell Senescence Assays
  • 2.6 Apoptosis
  • 2.7 Autophagy
  • 2.8 Necrosis
  • 2.9 Oxidative Stress
  • 2.10 2D vs. 3D
  • 2.11 Signalling Pathways, GPCR
  • 2.12 Immune Regulation & Inhibition
  • 2.13 Reporter Gene Technology
  • 2.14 CBA Design & Development
  • 2.15 Cell Based Assays - The Takeaway

3. Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Contract Research Organization
    • 3.1.3 Genomic Instrumentation Supplier
    • 3.1.5 Cell Line and Reagent Supplier
    • 3.1.6 Pharmaceutical Company
    • 3.1.7 Audit Body
    • 3.1.8 Certification Body

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Candidate Growth
    • 4.1.2 Immuno-oncology
    • 4.1.3 Genomic Blizzard
    • 4.1.4 Technology Convergence
    • 4.1.5 The Insurance Effect
  • 4.2 Factors Limiting Growth
    • 4.2.1 CBA Development Challenges
    • 4.2.2 Instrument Integration
    • 4.2.3 Protocols
  • 4.3 Technology Development
    • 4.3.1 3D Assays
    • 4.3.2 Automation
    • 4.3.3 Software
    • 4.3.4 Primary Cells
    • 4.3.5 Signalling and Reporter Genes
    • 4.3.6 The Next Five Years

5. Cell Based Assays Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
      • High-throughput Identifies cancer drug candidates
      • Velabs Therapeutics partners with Alytas Therapeutics to develop a
      • novel immune-based therapy for obesity
      • InSphero platform selected to test Cyclerion's sGC stimulator technology
      • OcellO to provide in vitro research services to Merus
      • Charles River Laboratories to acquire Citoxlab
      • Reaction Biology Corporation Purchases ProQinase GmbH
      • Cisbio extends its assay portfolio for immuno-oncology drug discovery
      • STEMCELL Technologies Launches Next-Generation Culture System
      • Abcam Acquires Calico Biolabs
      • Evotec announces achievement in Celgene alliance utilizing IPSC screening
      • Fujifilm Cellular Dynamics Inc. launches iCELL Microglia
      • Cisbio and Excellerate Bioscience partner
      • Agilent Acquires Luxcel Biosciences
      • Horizon Discovery extends CRISPR Screening Service to primary human T cells
      • BioIVT Acquires Biological Specialty Corporation
      • Miltenyi Biotec acquires microscopy specialist LaVision BioTec
      • BioIVT acquires Clinical Trials Laboratory Services
      • ACEA Biosciences to be Acquired by Agilent Technologies
      • Olympus announces new 3D Cell Analysis technology
      • Beckman Coulter Launches Flow Cytometry Software
      • Agilent Technologies Inc. and BioTek Instruments, Inc to Create
      • Integrated Metabolic Analysis and Imaging Platform
      • Molecular Devices launches new features for ImageXpress Pico
      • Automated Cell Imaging System
      • Ncardia Launches Custom CRISPR Gene-editing in iPSC-derived Cell
      • Lines with Horizon Discovery as Partner
      • MilliporeSigma to sell Flow Cytometry Unit
      • Charles River Laboratories purchases Nanion Syncropatch 384PE
      • Reaction Biology and Promega announce new NanoBRET Technology
      • Nanion Technologies and Ncardia to enhance Options for Cardiac Researchers
      • Citoxlab signs deal with Experimental Pharmacology and Oncology
      • Berlin-Buch GmbH (EPO)
      • Battery Ventures Acquires TTP Labtech Limited
      • BD Launches Cell Sorter to Enable Sorting of Rare Cell Types
      • Enzo Life Sciences Introduces Validated Antibodies for IHC
      • Sartorius launches new high throughput bioreactor system

6. Profiles of Key Cell Based Assay Companies

  • Abcam
  • Agilent
  • Beckman Coulter, Inc.
  • Becton Dickinson
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • Cell Biolabs, Inc
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories, Inc.
  • Cisbio Bioassays
  • Corning, Inc
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • GE Healthcare Life Sciences
  • Hemogenix
  • Horizon Discovery Group plc
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Merck KgaA
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc
  • Olympus
  • Origene Technologies
  • PerkinElmer, Inc
  • Promega Corporation
  • Qiagen NV
  • Reaction Biology
  • Roche Group
  • Sartorius
  • Sony Biotechnology
  • Stemcells Technologies Canada Inc.
  • Thermo Fisher Scientific, Inc.
  • TTP Labtech
  • Vitro Biopharma

7. Global Market Size

  • 7.1 Cell Based Assay Global Market Size by Region with Charts
  • 7.2 Cell Based Assays Global Market Size by Type with Charts

8. Global Market by User Type

  • 8.1 Pharmaceutical Market
    • 8.1.1 Pharmaceutical Market by Region with Chart
  • 8.2 Basic Research Market
    • 8.2.1 Basic Research Market by Region with Chart
  • 8.3 Industrial/Cosmetic Market
    • 8.3.1 Industrial/Cosmetic Market by Region with Chart

9. Cell Based Assay by Product Class

  • 9.1 Instrument Market
    • 9.1.1 Instrument Market by Region with Chart
  • 9.2 Reagent Market
    • 9.2.1 Reagent Market by Region with Chart
  • 9.3 Services Market
    • 9.3.1 Services Market by Region with Chart
  • 9.4 Software Market
    • 9.4.1 Software Market by Region with Chart

10. Appendices

  • 10.1 FDA Cancer Drug Approvals by Year
  • 10.2 Clinical Trials Started 2010 to 2016
  • 10.3 Share of Pharma R&D by Country

Table of Tables

  • Table 1 The Large Variety of Cell Lines
  • Table 2 Some Common Viability Assays
  • Table 3 Oxidative Stress Related Diseases
  • Table 4 Important Signalling Pathways
  • Table 5 Market Players by Type
  • Table 6 Five Factors Driving Growth
  • Table 7 Three Factors Limiting Growth
  • Table 8 Cell Based Assays Global Market by Region
  • Table 9 Cell Based Assays Global Market by User Type
  • Table 10 Pharmaceutical Market by Region
  • Table 11 Basic Research Market by Region
  • Table 12 Industrial/Cosmetic Market by Region
  • Table 13 Instrument Market by Region
  • Table 14 Reagent Market by Region
  • Table 15 Services Market by Region
  • TABLE 16 SOFTWARE MARKET BY REGION

Table of Figures

  • Figure 1 Reasons for clinical Failure by Phase
  • Figure 2 Immunotherapy Clinical Trial Growth
  • Figure 3 Pharmaceutical Research Expenditures 2001 to 2017 ($Billion)
  • Figure 4 Oxidative Stress and Free Radical Toxicity
  • Figure 5 FDA Cancer Drug Approvals
  • Figure 6 Growth rates of Cell Based Assays by Product Class
  • Figure 7 Market Size by Region
  • Figure 8 Global Market by Region
  • Figure 9 Chart of Global Market by User Type
  • Figure 10 Growth Rates of Industry Segments
  • Figure 11 Cell Based Assay Share Change by User Type
  • Figure 12 Chart - Pharmaceutical Market by Region
  • Figure 13 Chart - Basic Research Market by Region
  • Figure 14 Chart - Industrial/Cosmetic Market by Region
  • Figure 15 Chart - Instrument Market by Region
  • Figure 16 Chart - Reagent Market by Region
  • Figure 17 Chart -Services Market by Region
  • FIGURE 18 CHART -SOFTWARE MARKET BY REGION
  • Figure 19 FDA Cancer Drug Approvals by Year
  • Figure 20 Clinical Trials for Immunotherapy by Year
  • Figure 21 Share of Pharma R&D by Country
Back to Top